| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SAGENT PHARMACEUTICALS INC | 6,495,416 | 97,301,000 | 26.57% | ||
| 2 | ACLARIS THERAPEUTICS INC COM | 4,191,397 | 77,415,000 | 21.14% | ||
| 3 | EIGER BIOPHARMACEUTICALS INC | 1,599,591 | 31,704,000 | 8.66% | ||
| 4 | Nabriva Therapeutics AG | 3,151,700 | 23,638,000 | 6.46% | ||
| 5 | Ascendis Pharma | 1,766,832 | 23,446,000 | 6.40% | ||
| 6 | CODEXIS INC | 5,573,319 | 22,460,000 | 6.13% | ||
| 7 | Agile Therapeutics, Inc. | 2,019,955 | 15,372,000 | 4.20% | ||
| 8 | ADVANCED ACCELERATOR APPLIC | 455,798 | 13,781,000 | 3.76% | ||
| 9 | TREVENA INC | 1,728,000 | 10,886,000 | 2.97% | ||
| 10 | Capnia, Inc. | 7,456,984 | 8,650,000 | 2.36% | ||
| 11 | AIMMUNE THERAPEUTICS INC COM | 763,009 | 8,256,000 | 2.25% | ||
| 12 | REGENXBIO INC COM | 990,449 | 7,924,000 | 2.16% | ||
| 13 | AKARI THERAPEUTICS PLC | 527,842 | 7,121,000 | 1.94% | ||
| 14 | DYNAVAX TECHNOLOGIES CORP | 359,828 | 5,246,000 | 1.43% | ||
| 15 | ProNAi Therapeutics, Inc. | 2,438,270 | 4,852,000 | 1.33% | ||
| 16 | Carbylan Therapeutics Inc. | 4,204,562 | 2,775,000 | 0.76% | ||
| 17 | MINERVA NEUROSCIENCES INC COM | 200,000 | 2,042,000 | 0.56% | ||
| 18 | MEI PHARMA INC | 1,101,129 | 1,498,000 | 0.41% | ||
| 19 | REVANCE THERAPEUTICS INC COM | 77,373 | 1,052,000 | 0.29% | ||
| 20 | OCERA THERAPEUTICS INC | 153,331 | 291,000 | 0.08% | ||
| 21 | Capnia, Inc. | 943,858 | 245,000 | 0.07% | ||
| 22 | Zosano Pharma Corp | 98,515 | 125,000 | 0.03% | ||
| 23 | PALATIN TECHNOLOGIES INC COM | 234,909 | 103,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-16-013202, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
